These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2009-014409-15||Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis plus panretina...||bad-data|
|Ongoing||2009-014612-34||Prospective, multicenter, open-label study to evaluate the safety and efficacy of intravitreal ranibizumab in patients with subfoveal or juxtafoveal choroidal neovascularization (CNV) secondary to oth...||not-yet-due|
|Not reported||2009-016760-36||Prospective, randomized, open label phase II study to assess efficacy and safety of Macugen® (pegaptanib 0.3 mg intravitreal injections) plus panretinal photocoagulation (PRP) and PRP (monotherapy) in...||2012-10-31||due-trials|
|Not reported||2013-001215-73||Open, randomized and crossed-over study on the bioequivalence between tablets of 40 mg of furosemide from Ratiopharm - Comércio e Indústria de Produtos Farmacêuticos, Lda. (Furosemida Ratiopharm 40 mg...||2013-10-11||due-trials|
|Not reported||2013-001542-34||Open, randomized and crossed-over study on the bioequivalence between soft capsules of 100 mg of ciclosporine from Novartis Farma – Produtos Farmacêuticos, S.A. (Sandimmun Neoral®) and from Generis Fa...||2014-03-28||due-trials|
|Not reported||2013-003490-10||Intraocular Pressure And Tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or preservative free Latanoprost 0.005% Unit Dose (LUDPF) (Monopost)in patients with Ocular hyperte...||2015-02-17||due-trials|
|Reported results||2013-003640-23||Prospective, randomized, multicentre, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in ...||2016-05-27||due-trials|
|Not reported||2014-003491-23||A non-randomised, open-label, multicenter phase 4 pilot study on the effect and safety of Iluvien® in chronic diabetic macular edema patients considered insufficiently responsive to available therapie...||2016-03-09||due-trials|
|Ongoing||2015-001368-20||A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therap...||not-yet-due|